(Q62062033)
Statements
A Phase II Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study Investigating the Safety and Efficacy of Omnitram in Diabetic Neuropathy (English)
0 references
15 November 2018
0 references
July 2019
0 references
50
0 references
18 year
0 references
75 year
0 references